Scientists have finally pinpointed a molecular reason behind the muscle pain and weakness some people experience when taking statins, a crucial class of drugs for preventing heart disease. This breakthrough, achieved by researchers at the University of British Columbia (UBC) and the University of Wisconsin-Madison, could pave the way for developing statin medications with fewer side effects.
Statins are widely prescribed to lower cholesterol, significantly reducing the risk of heart attacks and strokes and saving millions of lives. However, muscle-related issues, ranging from mild soreness to rare but severe muscle breakdown, can be a limiting factor for some patients. The new research, published in Nature Communications, delves into how statins interact with a key protein in muscle cells called the ryanodine receptor (RyR1).
Using advanced cryo-electron microscopy, the team visualized how statins can disrupt the normal function of RyR1, a protein responsible for regulating calcium flow within muscle cells. Instead of acting as a precisely controlled gateway that opens only when needed for muscle contraction, statins cause the RyR1 channel to stick in an open position. This leads to a continuous leak of calcium, disrupting cellular balance and potentially causing muscle injury.
"We were able to see, almost atom by atom, how statins latch onto this channel," explained lead author Dr. Steven Molinarolo. "That leak of calcium explains why some patients experience muscle pain or, in extreme cases, life-threatening complications." The study focused on atorvastatin, a common statin, but the findings suggest similar mechanisms could affect other statin drugs.
A key discovery was that three molecules of atorvastatin work together to hold the calcium channel open. This detailed structural insight offers a "roadmap for designing statins that don't interact with muscle tissue," according to senior author Dr. Filip Van Petegem. By modifying the parts of statin molecules that bind to muscle proteins, researchers aim to create safer alternatives that maintain cholesterol-lowering power without the muscle pain.
Millions worldwide rely on statins, and even minor side effects can lead some to stop taking their medication, potentially increasing their cardiovascular risk. This new understanding offers hope for more tolerable treatments, allowing more patients to benefit from essential heart protection without the fear of debilitating muscle discomfort. While further research and drug development are needed, this discovery marks a significant step toward making statin therapy more comfortable and improving the quality of life for countless individuals.
